Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.33 USD | +4.02% | -9.88% | -7.32% |
Mar. 27 | HC Wainwright Adjusts BioAtla's Price Target to $7 From $10, Maintains Buy Rating | MT |
Mar. 26 | Transcript : BioAtla, Inc., Q4 2023 Earnings Call, Mar 26, 2024 |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 108M |
---|---|---|---|---|---|
Net income 2024 * | -107M | Net income 2025 * | -127M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.16
x | P/E ratio 2025 * |
-1.27
x | Employees | 65 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 90.15% |
Latest transcript on BioAtla, Inc.
1 day | +3.35% | ||
1 week | -9.88% | ||
Current month | -33.72% | ||
1 month | -2.15% | ||
3 months | +10.68% | ||
6 months | +70.15% | ||
Current year | -7.32% |
Managers | Title | Age | Since |
---|---|---|---|
Jay Short
CEO | Chief Executive Officer | 66 | 07-02-28 |
Founder | 59 | 07-02-28 | |
Richard Waldron
DFI | Director of Finance/CFO | 70 | 10-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Mary Gray
BRD | Director/Board Member | 71 | 20-11-30 |
Jay Short
CEO | Chief Executive Officer | 66 | 07-02-28 |
Director/Board Member | 76 | 15-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.03% | 0 M€ | 0.00% | - | |
0.02% | 0 M€ | 0.00% | - | |
0.01% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-24 | 2.31 | +3.12% | 15 272 |
24-04-23 | 2.24 | +2.75% | 672,657 |
24-04-22 | 2.18 | +3.56% | 872,008 |
24-04-19 | 2.105 | -13.37% | 796,590 |
24-04-18 | 2.43 | -3.95% | 362,131 |
Delayed Quote Nasdaq, April 24, 2024 at 09:35 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.32% | 108M | |
+5.08% | 43.43B | |
+48.83% | 41.69B | |
+9.60% | 41.31B | |
-10.82% | 27.14B | |
+9.56% | 25.28B | |
-23.58% | 18.47B | |
+37.34% | 12.59B | |
+2.37% | 12.33B | |
+6.48% | 11.03B |
- Stock Market
- Equities
- BCAB Stock